News & Perspective

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 26, 2007

Oct 26, 2007

THE PANDEMIC VACCINE PUZZLE Part 2: Vaccine production capacity falls far short

Editor's note: This is the second in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Aug 21, 2007

Aug 21, 2007

H5N1 strikes Pakistan poultry again

(CIDRAP News) – Government officials in Pakistan today announced a recent outbreak of H5N1 avian influenza at a poultry farm in the country's northwest, as Indonesia worked to stamp out the disease on farms on Sulawesi and Italian officials reported low-pathogenic avian flu outbreaks.

Mar 23, 2007

Mar 23, 2007

Bangladesh, Saudi Arabia report first H5N1 outbreaks

(CIDRAP News) – Agriculture officials in Bangladesh and Saudi Arabia have confirmed outbreaks of H5N1 avian influenza in birds, a first for each country.

The outbreak in Bangladesh struck chickens at a state-run poultry farm in Savar, near the capital, Dhaka, the Associated Press (AP) reported today. Government sources said farm workers had recently culled all 30,000 chickens at the farm after many of them died mysteriously, the AP said.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»